In fiscal year 2023, the global malaria treatment market is expected to be worth US$ 1.8 billion, up from US$ 1.72 billion in fiscal year 2022. The market is expected to grow at a 5% CAGR from 2023 to 2033, reaching a value of US$ 2.93 billion by the end of 2033.
The World Intellectual Property Organization (WIPO) defines malaria as an infectious, potentially fatal disease that affected more than 210 million people worldwide in 2019. It is caused by a small parasite called Plasmodium, which mosquitos transmit to humans. There are four different Plasmodium species that can cause malaria, but Plasmodium falciparum is the most lethal.
Malaria patients frequently experience fever, headache, vomiting, and shivering, but more severe cases can also present with severe anaemia, breathing difficulties, organ failure, and nervous system problems. To detect the presence of the disease and keep an eye out for relapses, a variety of diagnostic procedures can be used, including thick blood smears, fast antigen tests, molecular tests, antibody tests, and susceptibility tests.
Malaria Treatment Market: Segmentation
Valuable information covered in the FMI’s Malaria Treatment market report has been segregated into key segments and sub-segments.
Malaria Treatment Market by Treatment:
- Prescription Medications
- Vaccines
- Diagnostic Tests
- Others
Malaria Treatment Market by Drug Type:
- Branded
- Generic
Malaria Treatment Market by Route of Administration:
- Oral and Parenteral
- Intravenous
Malaria Treatment Market by Distribution Channel:
- Direct Tender
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Malaria Treatment Market by End User:
- Hospitals
- Specialty Clinics
- Homecare
- Others
Browse More Details@ https://www.futuremarketinsights.com/reports/malaria-treatment-market
Key players covered in the report include:
- Zydus Healthcare Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sanofi SA
- GSK Plc.
- Novartis AG
- Cipla Ltd.
- Viatris Inc.
- Lupin Ltd.
- Advacare Pharma USA LLC
- VLP Therapeutics LLC
